Disease & disorder

appendix carcinoma

MONDO:0003196

A carcinoma that arises from epithelial cells of the vermiform appendix

Clinical trials7
Recruiting0
Drug concepts studied3
Synonyms6

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

appendix carcinoma

Wikidata Q18556534 ↗
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

7 shown
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsNCT04985357 · 2024-11-01
WITHDRAWN
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)NCT05461430 · 2022-07-15
COMPLETED
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)NCT01126346 · 2010-05-01
COMPLETED
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerNCT00397384 · 2007-01-01
COMPLETED
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerNCT00087191 · 2004-05-01
TERMINATED
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)NCT00031681 · 2001-12-01
COMPLETED
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuNCT00004074 · 1999-08-01
COMPLETED

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.